Zenith Drugs (NSE:ZENITHDRUG) Issuance of Debt: ₹158 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ZENITHDRUG Zenith Drugs Ltd NSE:ZENITHDRUG
40 GF Score
Price ₹46.35
! 6 Warning Signs
View Full Analysis

What is Zenith Drugs Issuance of Debt?

Zenith Drugs NSE:ZENITHDRUG -3.64% 40 Issuance of Debt is ₹158 Mil as of Mar. 2026. GuruFocus rates NSE:ZENITHDRUG with a GF Score™ of 40/100. The stock has 6 warning signs investors should review.

Zenith Drugs's Issuance of Debt for the six months ended in Mar. 2026 was ₹0 Mil.

Zenith Drugs's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was ₹158 Mil.

Zenith Drugs Issuance of Debt Related Terms

Zenith Drugs Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Zenith Drugs's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Drugs Issuance of Debt Chart

Zenith Drugs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Issuance of Debt
Get a 7-Day Free Trial 33.28 73.02 0.00 234.50 0.00

Zenith Drugs Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 157.55 0.00
NSE:ZENITHDRUG
40GF Score
Zenith Drugs Ltd NSE:ZENITHDRUG
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenith Drugs Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹158 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of ₹158 Mil mean?
Zenith Drugs (NSE:ZENITHDRUG) has a Issuance of Debt of ₹158 Mil as of Mar. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Zenith Drugs and its competitors.
Is Zenith Drugs' Issuance of Debt too high?
Zenith Drugs' current Issuance of Debt is ₹158 Mil. Overall, Zenith Drugs has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Zenith Drugs' Issuance of Debt compare to ZTS?
Zenith Drugs' Issuance of Debt of ₹158 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Drug Manufacturers company?
A good Issuance of Debt depends on the Drug Manufacturers industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Zenith Drugs and its competitors. Zenith Drugs's current Issuance of Debt is ₹158 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Drugs stock overvalued right now?
Zenith Drugs (NSE:ZENITHDRUG) has a current Issuance of Debt of ₹158 Mil. The current Issuance of Debt is ₹158 Mil. Zenith Drugs' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Zenith Drugs (NSE:ZENITHDRUG), the current Issuance of Debt is ₹158 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zenith Drugs Business Description

Address K. No. 72/5, Village Muradpura, Depalpur, Indore, MP, IND, 453001
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, Creams, Gels, Capsules, and Tablets. It is also into Generic Medicines.
40GF Score

Get the complete analysis for NSE:ZENITHDRUG

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹46.35
Price